Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

被引：0
作者：
Margaret von Mehren
Michael Bookman
Neal J. Meropol
Louis M. Weiner
Eric Sherman
Jinhui Li
Roland Knoblauch
Trilok Parekh
Roger B. Cohen
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] US Oncology Research,Arizona Oncology
[3] University Hospitals Case Medical Center,Hematology and Oncology
[4] Seidman Cancer Center,undefined
[5] Georgetown University Medical Center,undefined
[6] Memorial Sloan-Kettering Cancer Center,undefined
[7] Janssen Research & Development,undefined
[8] LLC,undefined
[9] University of Pennsylvania,undefined
[10] Case Comprehensive Cancer Center,undefined
[11] Case Western Reserve University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Advanced malignancies; Combination chemotherapy; Docetaxel; Ovarian cancer; Sarcoma; Trabectedin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1047 / 1055
页数：8
相关论文
共 50 条
  • [21] Phase I study of Doxil® and vinorelbine in patients with advanced malignancies
    Laufman, LR
    Spiridonidis, CH
    Jones, JJ
    Rhodes, V
    Rossi, K
    Wallace, K
    CANCER INVESTIGATION, 2004, 22 (03) : 344 - 352
  • [22] A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
    Deeken, John F.
    Slack, Rebecca
    Weiss, Glen J.
    Ramanathan, Ramesh K.
    Pishvaian, Michael J.
    Hwang, Jimmy
    Lewandowski, Karen
    Subramaniam, Deepa
    He, Aiwu Ruth
    Cotarla, Ion
    Rahman, Aquilur
    Marshall, John L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 627 - 633
  • [23] Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
    Vidal, Laura
    Magem, Margarita
    Barlow, Clare
    Pardo, Beatriz
    Florez, Amalia
    Montes, Ana
    Garcia, Margarita
    Judson, Ian
    Lebedinsky, Claudia
    Kaye, Stan B.
    Salazar, Ramon
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 616 - 628
  • [24] Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
    Laura Vidal
    Margarita Magem
    Clare Barlow
    Beatriz Pardo
    Amalia Florez
    Ana Montes
    Margarita Garcia
    Ian Judson
    Claudia Lebedinsky
    Stan B. Kaye
    Ramón Salazar
    Investigational New Drugs, 2012, 30 : 616 - 628
  • [25] Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study
    Masuda, Norikazu
    Iwata, Hiroji
    Aogi, Kenjiro
    Xu, Yihuan
    Ibrahim, Ayman
    Gao, Ling
    Dalal, Rita
    Yoshikawa, Reigetsu
    Sasaki, Yasutsuna
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1088 - 1094
  • [26] A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
    Yong, Wei-Peng
    Wang, Ling-Zhi
    Tham, Lai-San
    Wong, Chiung-Ing
    Lee, Soo-Chin
    Soo, Ross
    Sukri, Norita
    Lee, How-Sung
    Goh, Boon-Cher
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 243 - 251
  • [27] A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
    Wei-Peng Yong
    Ling-Zhi Wang
    Lai-San Tham
    Chiung-Ing Wong
    Soo-Chin Lee
    Ross Soo
    Norita Sukri
    How-Sung Lee
    Boon-Cher Goh
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 243 - 251
  • [28] Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
    Pronk, LC
    Schrijvers, D
    Schellens, JHM
    de Bruijn, EA
    Planting, AST
    Locci-Tonelli, D
    Groult, V
    Verweij, J
    van Oosterom, AT
    BRITISH JOURNAL OF CANCER, 1998, 77 (01) : 153 - 158
  • [29] Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
    G Marx
    C Lewis
    K Hall
    J Levi
    S Ackland
    British Journal of Cancer, 2002, 87 : 846 - 849
  • [30] Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
    Marx, G
    Lewis, C
    Hall, K
    Levi, J
    Ackland, S
    BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 846 - 849
12345